#ITI#Single vaccination provides limited protection to ducks and geese against H5N1 high pathogenicity avian influenza virus#FTI#
#IRE#Since 2002, high pathogenicity avian influenza (HPAI) has spread from Asia to Europe and into Africa, causing the largest epizootic of HPAI of the last 50 yr, including infecting domestic and wild waterfowl. Our study was conducted to investigate whether a single vaccination of 7-day-old domestic ducks and geese with inactivated oil emulsion vaccines resulted in protection against HPAI virus challenge at 30 days of age. In ducks, some but not all vaccines decreased oropharyngeal and cloacal viral shedding for different periods postchallenge when compared with the sham group. In geese, decreased morbidity signs and mortality were noted but limited to some vaccines. Best protection was seen with a vaccine homologous to HPAI challenge virus. Limited decreases in oropharyngeal and cloacal viral shedding and mixed results were attained when looking at seroconversion. Our results indicate a single dose of oil-emulsified vaccine optimized for chickens did not provide adequate protection for ducks and geese against HPAI virus, and, at a minimum, additional research is needed to formulate waterfowl-specific vaccines. Â© American Association of Avian Pathologists 2010.#FRE#
#IPC#ducks; geese; H5N1; highly pathogenic avian influenza; inactivated vaccine; vaccine#FPC#
#IRF#Alexander D.J., Brown I.H., History of highly pathogenic avian influenza, Rev. Sci. Tech., 28, pp. 19-38, (2009); 
Beard C.W., Demonstration of type-specific influenza antibody in mammalian and avian sera by immunodiffusion, Bull. World Health Organ., 42, pp. 779-785, (1970); 
Beato M.S., Toffan A., De Nardi R., Cristalli A., Terregino C., Cattoli G., Capua I., A conventional, inactivated oil emulsion vaccine suppresses shedding and prevents viral meat colonisation in commercial (Pekin) ducks challenged with HPAI H5N1, Vaccine, 25, pp. 4064-4072, (2007); 
Bertelsen M.F., Klausen J., Holm E., Grondahl C., Jorgensen P.H., Serological response to vaccination against avian influenza in zoo-birds using an inactivated H5N9 vaccine, Vaccine, 25, pp. 4345-4349, (2007); 
Bublot M., Le Gros F.X., Nieddu D., Pritchard N., Mickle T.R., Swayne D.E., Efficacy of two H5N9-inactivated vaccines against challenge with a recent H5N1 highly pathogenic avian influenza isolate from a chicken in Thailand, Avian Dis., 51, pp. 332-337, (2007); 
Cauthen A.N., Swayne D.E., Schultz-Cherry S., Perdue M.L., Suarez D.L., Continued circulation in China of highly pathogenic avian influenza viruses encoding the hemagglutinin gene associated with the 1997 H5N1 outbreak in poultry and humans, J. Virol., 74, pp. 6592-6599, (2000); 
Chen H., Deng G., Li Z., Tian G., Li Y., Jiao P., Zhang L., Liu Z., Webster R.G., Yu K., The evolution of H5N1 influenza viruses in ducks in southern China, Proc. Natl. Acad. Sci. U. S. A., 101, pp. 10452-10457, (2004); 
Chen H., Subbarao K., Swayne D., Chen Q., Lu X., Katz J., Cox N., Matsuoka Y., Generation and evaluation of a high-growth reassortant H9N2 influenza A virus as a pandemic vaccine candidate, Vaccine, 21, pp. 1974-1979, (2003); 
Ellis T.M., Bousfield R.B., Bissett L.A., Dyrting K.C., Luk G.S., Tsim S.T., Sturm-Ramirez K., Webster R.G., Guan Y., Malik J.S., Peiris investigation of outbreaks of highly pathogenic H5N1 avian influenza in waterfowl and wild birds in Hong Kong in late 2002, Avian Pathol., 33, pp. 492-505, (2004); 
Gilbert M., Chaitaweesub P., Parakamawongsa T., Premashthira S., Tiensin T., Kalpravidh W., Wagner H., Slingenbergh J., Free-grazing ducks and highly pathogenic avian influenza, Thailand. Emerg. Infect. Dis., 12, pp. 227-234, (2006); 
Goetz S.K., Spackman E., Hayhow C., Swayne D.E., Assessment of reduced vaccine dose on efficacy of an inactivated avian influenza vaccine against an H5N1 high-pathogenicity avian influenza virus, J. Appl. Poult. Res., 17, pp. 145-150, (2008); 
Guan Y., Peiris M., Kong K.F., Dyrting K.C., Ellis T.M., Sit T., Zhang L.J., Shortridge K.F., H5N1 influenza viruses isolated from geese in southeastern China: Evidence for genetic reassortment and interspecies transmission to ducks, Virology, 292, pp. 16-23, (2002); 
Guan Y., Shortridge K.F., Krauss S., Chin P.S., Dyrting K.C., Ellis T.M., Webster R.G., Peiris M., H9N2 influenza viruses possessing H5N1-like internal genomes continue to circulate in poultry in southeastern China, J. Virol., 74, pp. 9372-9380, (2000); 
Guan Y., Shortridge K.F., Krauss S., Webster R.G., Molecular characterization of H9N2 influenza viruses: Were they the donors of the "internal" genes of H5N1 viruses in Hong Kong?, Proc. Natl. Acad. Sci. U. S. A., 96, pp. 9363-9367, (1999); 
Hulse-Post D.J., Sturm-Ramirez K.M., Humberd J., Seiler P., Govorkova E.A., Krauss S., Scholtissek C., Puthavathana P., Buranathai C., Nguyen T.D., Long H.T., Naipospos T.S., Chen H., Ellis T.M., Guan Y., Peiris J.S., Webster R.G., Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia, Proc. Natl. Acad. Sci. U. S. A., 102, pp. 10682-10687, (2005); 
Kilbourne E.D., Future influenza vaccines and the use of genetic recombinants, Bull. WHO, 41, pp. 643-645, (1969); 
Kim J.K., Seiler P., Forrest H.L., Khalenkov A.M., Franks J., Kumar M., Karesh W.B., Gilbert M., Sodnomdarjaa R., Douangngeun B., Govorkova E.A., Webster R.G., Pathogenicity and vaccine efficacy of different clades of Asian H5N1 avian influenza A viruses in domestic ducks, J. Virol., 82, pp. 11374-11382, (2008); 
Martin V., Sims L., Lubroth J., Pfeiffer D., Slingenbergh J., Domenech J., Epidemiology and ecology of highly pathogenic avian influenza with particular emphasis on South East Asia, Dev. Biol., 124, pp. 23-36, (2006); 
Middleton D., Bingham J., Selleck P., Lowther S., Gleeson L., Lehrbach P., Robinson S., Rodenberg J., Kumar M., Andrew M., Efficacy of inactivated vaccines against H5N1 avian influenza infection in ducks, Virology, 359, pp. 66-71, (2007); 
Muramoto Y., Le T.Q., Phuong L.S., Nguyen T., Nguyen T.H., Sakai-Tagawa Y., Horimoto T., Kida H., Kawaoka Y., Pathogenicity of H5N1 influenza A viruses isolated in Vietnam between late 2003 and 2005, J. Vet. Med. Sci., 68, pp. 735-737, (2006); 
Perkins L.E., Swayne D.E., Pathogenicity of a Hong Kong-origin H5N1 highly pathogenic avian influenza virus for emus, geese, ducks, and pigeons, Avian Dis., 46, pp. 53-63, (2002); 
Pfeiffer J.S.D., Sarmento L., To T.L., Nguyen T., Pantin-Jackwood M.J., Efficacy of commercial vaccines in protecting chickens and ducks against H5N1 highly pathogenic avian influenza viruses from Vietnam, Avian Dis., 54, SUPPL., pp. 262-271, (2010); 
Rudolf M., Poppel M., Frohlich A., Mettenleiter T., Beer M., Harder T., Efficacy of a commercial inactivated H5 influenza vaccine against highly pathogenic avian influenza H5N1 in waterfowl evaluated under field conditions, Rev. Sci. Tech., 28, pp. 275-291, (2009); 
Songserm T., Jam-On R., Sae-Heng N., Meemak N., Hulse-Post D.J., Sturm-Ramirez K.M., Webster R.G., Domestic ducks and H5N1 influenza epidemic, Thailand. Emerg. Infect. Dis., 12, pp. 575-581, (2006); 
Steensels M., Bublot M., Van Borm S., De Vriese J., Lambrecht B., Richard-Mazet A., Chanavat-Bizzini S., Duboeuf M., Le Gros F.X., Berg Den T.Van, Prime-boost vaccination with a fowlpox vector and an inactivated avian influenza vaccine is highly immunogenic in Pekin ducks challenged with Asian H5N1 HPAI, Vaccine, 27, pp. 646-654, (2009); 
Sturm-Ramirez K.M., Ellis T., Bousfield B., Bissett L., Dyrting K., Rehg J.E., Poon L., Guan Y., Peiris M., Webster R.G., Reemerging H5N1 influenza viruses in Hong Kong in 2002 are highly pathogenic to ducks, J. Virol., 78, pp. 4892-4901, (2004); 
Subbarao K., Katz J.M., Influenza vaccines generated by reverse genetics, Curr. Top. Microbiol. Immunol., 283, pp. 313-342, (2004); 
Subbarao K., Klimov A., Katz J., Regnery H., Lim W., Hall H., Perdue M., Swayne D., Bender C., Huang J., Hemphill M., Rowe T., Shaw M., Xu X., Fukuda K., Cox N., Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness, Science, 279, pp. 393-396, (1998); 
Swayne D.E., Application of new vaccine technologies for the control of transboundary diseases, Dev. Biol. (Basel), 119, pp. 219-228, (2004); 
Swayne D.E., A Laboratory Manual for the Isolation and Identification of Avian Pathogens, 4th Ed, (1998); 
Swayne D.E., Beck J.R., Garcia M., Stone H.D., Influence of virus strain and antigen mass on efficacy of H5 avian influenza inactivated vaccines, Avian Pathol., 28, pp. 245-255, (1999); 
Swayne D.E., Lee C.W., Spackman E., Inactivated North American and European H5N2 avian influenza virus vaccines protect chickens from Asian H5N1 high pathogenicity avian influenza virus, Avian Pathol., 35, pp. 141-146, (2006); 
Takada A., Kuboki N., Okazaki K., Ninomiya A., Tanaka H., Ozaki H., Itamura S., Nishimura H., Enami M., Tashiro M., Shortridge K.F., Kida H., Avirulent avian influenza virus as a vaccine strain against a potential human pandemic, J. Virol., 73, pp. 8303-8307, (1999); 
Tian G., Zhang S., Li Y., Bu Z., Liu P., Zhou J., Li C., Shi J., Yu K., Chen H., Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics, Virology, 341, pp. 153-162, (2005); 
Tumpey T.M., Suarez D.L., Perkins L.E., Senne D.A., Lee J.G., Lee Y.J., Mo I.P., Sung H.W., Swayne D.E., Characterization of a highly pathogenic H5N1 avian influenza A virus isolated from duck meat, J. Virol., 76, pp. 6344-6355, (2002); 
Van Der Goot J.A., Van Boven M., De Jong M.C.M., Koch G., Effect of vaccination on transmission of HPAI H5N1: The effect of a single vaccination dose on transmission of highly pathogenic avian influenza H5N1 in Peking ducks, Avian Diseases, 51, SUPPL. 1, pp. 323-324, (2007); 
Van Der Goot J.A., Van Boven M., Stegeman A., Van De Water S.G., De Jong M.C., Koch G., Transmission of highly pathogenic avian influenza H5N1 virus in Pekin ducks is significantly reduced by a genetically distant H5N2 vaccine, Virology, 382, pp. 91-97, (2008); 
Webster R.G., Guan Y., Peiris M., Walker D., Krauss S., Zhou N.N., Govorkova E.A., Ellis T.M., Dyrting K.C., Sit T., Perez D.R., Shortridge K.F., Characterization of H5N1 influenza viruses that continue to circulate in geese in southeastern China, J. Virol., 76, pp. 118-126, (2002); 
Webster R.G., Guan Y., Poon L., Krauss S., Webby R., Govorkovai E., Peiris M., The spread of the H5N1 bird flu epidemic in Asia in 2004, Arch. Virol. Suppl., 19, pp. 117-129, (2005); 
Webster R.G., Peiris M., Chen H., Guan Y., H5N1 outbreaks and enzootic influenza, Emerg. Infect. Dis., 12, pp. 3-8, (2006); 
Webster R.G., Webby R.J., Hoffmann E., Rodenberg J., Kumar M., Chu H.J., Seiler P., Krauss S., Songserm T., The immunogenicity and efficacy against H5N1 challenge of reverse genetics-derived H5N3 influenza vaccine in ducks and chickens, Virology, 351, pp. 303-311, (2006); 
Xu X., Subbarao N., Cox J., Guo Y., Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/ 96 (H5N1) virus: Similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong, Virology, 261, pp. 15-19, (1999); 
Zambon M., Laboratory containment for influenza A H5N1 virus: Level 2, level 3, or level 3+? Commun, Dis. Public Health, 1, pp. 71-72, (1998)#FRF#
